IP Library Granted Patent US 8,039,617
Granted Patent B2
US 8,039,617 · App. 11/910,498 · Granted Oct 18, 2011

Method for producing alpha form crystals of sapropterin hydrochloride

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,039,617
App. No.
11/910,498
Granted
Oct 18, 2011
Kind
B2
Abstract

A method for selectively producing stable alpha form crystals of sapropterin hydrochloride is provided. In this method, the alpha form crystal of sapropterin hydrochloride is produced by dissolving sapropterin hydrochloride with hydrochloric acid at a concentration of not less than 4 mol/L at not less than 70 degrees C.; adding heated ethanol to the solution; and cooling the solution at a cooling rate of not faster than 3 degrees C./min to a temperature of 40 to 55 degrees C. to precipitate the crystals.

Claims (4)

1. A method for producing α form crystal of sapropterin hydrochloride comprising the steps of dissolving sapropterin hydrochloride with hydrochloric acid at a concentration of not less than 4 mol/L at not less than 70° C.; adding heated ethanol to the solution; and cooling the solution at a cooling rate of not faster than 3° C./min to a temperature of 40 to 55° C. to precipitate the crystals.

2. The production method according to claim 1 wherein the sapropterin hydrochloride is dissolved at a temperature in the range of 75 to 80° C.

3. The production method according to claim 1 or 2 wherein the ethanol is used at an amount of 2 to 10-fold volume in relation to the solution of sapropterin hydrochloride in hydrochloric acid.

4. The production method according to claim 1 wherein the cooling rate is in the range of 0.1 to 3° C./min.

Assignments (4)
SECURITY INTEREST Recorded Apr 27, 2026
From: BIOMARIN PHARMACEUTICAL INC.; AMICUS THERAPEUTICS, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075493/0968 →
MERGER Recorded Jun 3, 2010
From: ASUBIO PHARMA CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 024480/0036 →
CORRECTIVE ASSIGNMENT TO CORRECT THE 1ST ASSIGNEE'S CITY PREVIOUSLY RECORDED ON REEL 019908 FRAME 0794. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 18, 2007
From: HOTODA, KATSUMI; KIYONO, HIROOMI; TAZAWA, SHINNOSUKE
To: SHIRATORI PHARMACEUTICAL CO., LTD.; ASUBIO PHARMA CO., LTD.
Reel/Frame 019978/0707 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2007
From: HOTODA, KATSUMI; KIYONO, HIROOMI; TAZAWA, SHINNOSUKE
To: SHIRATORI PHARMACEUICAL CO.,LTD.; ASUBIO PHARMA CO., LTD
Reel/Frame 019908/0794 →